← Open Payments lookup

KERRI GRIFFIN: Open Payments

NPI 1861007957 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,208 in 53 payments from 17 companies in 2025. Trend: 2023 $877 · 2024 $1,157 · 2025 $1,208

Food & beverage: $1,205Education: $3
CompanyPaymentsAmount
Vifor Pharma, Inc.7$162
Medtronic, Inc.4$151
AstraZeneca Pharmaceuticals LP7$137
Travere Therapeutics, Inc.6$100
Bayer Healthcare Pharmaceuticals Inc.4$86
OPKO Pharmaceuticals, LLC5$82
Boehringer Ingelheim Pharmaceuticals, Inc.3$82
Fresenius USA Marketing, Inc.3$71
SCPHARMACEUTICALS INC.3$66
Novartis Pharmaceuticals Corporation2$63

Products named: Veltassa, SYMPLICITY G3, FARXIGA, Kerendia, RAYALDEE, JARDIANCE, VELPHORO, FUROSCIX.

Industry payments across AL — which companies pay providers there.